Methylene Blue Spray for Identification of Recurrent Laryngeal Nerve and Parathyroid Gland
1 other identifier
interventional
80
1 country
1
Brief Summary
Thyroidectomy is the procedure by which surgeons treat various thyroid diseases and is considered the commonest endocrinal surgery. Yet, it carries a risk for intraoperative complications. The most distressing complications are recurrent laryngeal nerve and parathyroid injuries. Methylene blue spray is a technique than can be used for easy identification of both recurrent laryngeal nerve and parathyroid glands so we can avoid their injuries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2021
CompletedFirst Submitted
Initial submission to the registry
October 28, 2021
CompletedFirst Posted
Study publicly available on registry
November 9, 2021
CompletedNovember 9, 2021
October 1, 2021
1.4 years
October 28, 2021
October 28, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
detection of the recurrent larngeal nerve unstained
the methylene blue dye stain the background and the RLN appears unstained
one minute after dye application
detection of the parathyroig glands
the methylene blue dye stain washed out and the parathyroid gland remained stained after 3 minutes
3 minutes after dye application
Study Arms (2)
anatomical identification
NO INTERVENTIONthyroidectomy was done with identification of both RLN and parathyroid gland done on anatomical basis
methylene blue identification
SHAM COMPARATORthyroidectomy was done with identification of both RLN and parathyroid gland done using methylene blue spray (0.5 ml methylene blue 2% was diluted by 5ml normal saline) was sprayed over the lower thyroid pole and the perilobar area
Interventions
After ligation of the middle thyroid vein and the upper pole of the thyroid, the thyroid lobe was retracted medially and diluted methylene blue (0.5 ml methylene blue 2% was diluted by 5ml normal saline) was sprayed over the lower thyroid pole and the perilobar area. This area contains structures including recurrent laryngeal nerve, parathyroid glands, and inferior thyroid vessels which were observed After spraying. The vocal cord mobility was assessed intraoperatively by the anesthesiologist at time of extubation. The serum calcium was measured on the 2nd postoperative day. There was no routine use of postoperative calcium supplementation. Hypocalcemia was defined when the serum calcium level was less than 8 mg/dl.
Eligibility Criteria
You may qualify if:
- Age of 16 years and older.
- Both sexes.
- Patients who are candidate for thyroid surgery and euthyroid.
You may not qualify if:
- \- Patients with hyper- or hypo-thyroid status.
- Patients who were unfit for surgery.
- Patients with unilateral or bilateral vocal cord palsy on preoperative indirect laryngoscopy
- Patients with thyroid malignancy by preoperative FNAC.
- Patients with hypersensitivity to methylene blue were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zagazig university hospitals
Zagazig, 44511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
October 28, 2021
First Posted
November 9, 2021
Study Start
January 15, 2020
Primary Completion
June 10, 2021
Study Completion
July 15, 2021
Last Updated
November 9, 2021
Record last verified: 2021-10